Perspective Therapeutics, Inc. — Director's Dealing 2013

Sep 10, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2013-09-05

Reporting Person: Babcock Dwight William (Director, CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-09-05	Stock Options	$0.58	A	50000	Acquired	2023-09-05	Common Stock (50000)	Direct

Footnotes

F1: Right to Buy